• Diet & Nutrition
  • Weight Loss
  • Lifestyle
  • Mental Well-Being
  • Self Improvements
  • Workouts & Exercise
  • News

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Keto avocado toast with crispy feta eggs

November 14, 2026

Low carb biscotti with almonds and pistachios

November 13, 2026

Perspective vs Prescription: Hard Days Make for Soft Landings

November 13, 2026
Facebook Twitter Instagram
Facebook Twitter Instagram Vimeo
Fitnessvivid.com
Subscribe Login
  • Diet & Nutrition

    Sweet Potato Dessert for Menopause (No Added Sugar)

    November 13, 2026

    5 Wall Exercises That Firm Inner Thighs Faster Than Gym Classes After 65

    November 12, 2026

    Chicken grinder salad in lettuce cups

    November 11, 2026

    Shakeology vs. Ka’Chava: Which Is the Best Nutritional Shake?

    November 10, 2026

    5 Daily Exercises Men Over 65 Need to Keep Their Heart Strong

    November 9, 2026
  • Weight Loss

    Keto avocado toast with crispy feta eggs

    November 14, 2026

    Keto chicken and waffles with poached eggs

    November 13, 2026

    Peri-peri chicken with roasted cauliflower

    November 12, 2026

    Low carb Turkish pasta with cabbage noodles

    November 11, 2026

    Keto blinis with smoked salmon

    November 8, 2026
  • Lifestyle

    The Best CBD THC Gummies for 2026

    September 29, 2026

    care validate epm – version 1

    August 6, 2026

    noom weight epm

    April 9, 2026

    noom weight epm

    April 4, 2026

    How to Get Rid of Mosquito Bites Overnight: Home Remedies

    March 20, 2026
  • Mental Well-Being

    Success and Fulfillment: Why High Achievers…

    May 24, 2026

    Therapy Is Where Change Begins. Habits Are …

    May 23, 2026

    How Your Feed Is Quietly Running Your Nervo…

    May 16, 2026

    Caught in the Chronic Pain Cycle? How Thera…

    May 12, 2026

    Perfectionism: When High Standards Help and…

    May 11, 2026
  • Self Improvements

    Perspective vs Prescription: Hard Days Make for Soft Landings

    November 13, 2026

    15 Home Gifts That Make Everyday Living Feel Luxurious

    November 12, 2026

    The Molecular Messengers Transforming Women’s Health After 35

    November 11, 2026

    Best Beauty Gifts of 2026: Editor-Approved Picks

    November 10, 2026

    12 Days of Smelling Delicious? DedCool Has Us Covered

    November 9, 2026
  • Workouts & Exercise

    Low carb biscotti with almonds and pistachios

    November 13, 2026

    Low carb lomo saltado with kohlrabi fries

    November 11, 2026

    Low carb chicken Pad Thai with zoodles

    November 6, 2026

    Keto olive oil cake with whipped cream

    November 1, 2026

    Million dollar cabbage with ground beef

    October 30, 2026
  • News

    At 43, Robert Strauss Continues Training to Be the ‘Dad Bod Destroyer’

    November 13, 2026

    Stephan James Cut Weight in Order to Look Bigger for ‘I Play Rocky’

    November 12, 2026

    2026 Romania Muscle Fest Pro Results: Ahmed Juraybi Wins Men’s Open

    November 11, 2026

    Have Today’s Strength Machines Finally Caught Up with Free Weights for Muscle Growth?

    November 10, 2026

    Are Your Gains Stalling? Here’s Why Your Training Needs to Keep Evolving

    November 9, 2026
Fitnessvivid.com
Home»Workouts & Exercise»New study finds triple-negative breast cancer tumors with an increase in immune cells have lower risk of recurrence after surgery
Workouts & Exercise

New study finds triple-negative breast cancer tumors with an increase in immune cells have lower risk of recurrence after surgery

adminBy adminApril 3, 2024No Comments7 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
a close up of woman wearing a pink ribbon for breast cancer awareness on her white t-shirt
Share
Facebook Twitter LinkedIn Pinterest Email


ROCHESTER, Minn. — A new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cells within their tumors may have a lower risk of recurrence and better survival rates even when not treated with chemotherapy. The study was published today in the Journal of American Medical Association (JAMA).

TNBC is a breast cancer subtype that does not respond to drugs that target the estrogen receptor or the HER2 protein. It grows rapidly, is more likely to spread beyond the breast before diagnosis and is more likely to recur than other breast cancers. TNBC represents about 15% of all breast cancers and is more common in younger people and in women of African American, Hispanic and Indian descent. Immune cells, also known as tumor-infiltrating lymphocytes, or TILs, are naturally existing immune system cells that can move from the bloodstream into a tumor and can recognize and destroy cancer cells.

This is a tumor from a patient where the immune cells, also known as tumor-infiltrating lymphocytes or TILs, (blue arrow) are attacking the cancer (yellow arrow). The study shows that patients with these findings had a good outcome, even when chemotherapy was not administered.

“This is an important finding because it highlights that the abundance of TILs in breast tissue is a prognostic biomarker in people with early-stage triple-negative breast cancer, even when chemotherapy is not administered,” says Roberto Leon-Ferre, M.D., a breast medical oncologist at Mayo Clinic Comprehensive Cancer Center and first author of the study. “The study’s findings may inspire future clinical trials to explore whether patients with a favorable prognosis (high TILs) can avoid intensive chemotherapy regimens.”

“This meta-analysis confirms robustly the prognostic value of TILs that we have previously reported in TNBC patients treated with chemotherapy and expands it to patients treated without chemotherapy,” says Sarah Flora Jonas, Ph.D., a statistician at Gustave Roussy and co-first author of the study. “Future studies may allow the use of this biomarker along with standard clinicopathological factors to inform treatment decisions in TNBC patients.”

“Of interest, the first report suggesting that an increased number of immune cells being associated with better prognosis in breast cancer patients was described by doctors at Mayo Clinic more than 100 years ago,” says Roberto Salgado, M.D., co-chair of the International Immuno-Oncology Biomarker Working Group; co-lead of the study; and pathologist from the Peter MacCallum Cancer Centre, Melbourne, Australia, and ZAS Hospitals, Antwerp, Belgium. “It took a global effort and a century later to reexamine this biomarker and bring it closer to application in patient care.”

This is a tumor from a patient where there are no immune cells, so the immune system of the patient is not attacking the cancer (yellow arrow).
These patients have a higher risk of recurrence, particularly without chemotherapy.

“TILs are not currently measured or reported in the routine examination of tissue samples of breast cancer,” says co-senior author, Matthew Goetz, M.D., a medical oncologist at Mayo Clinic Comprehensive Cancer Center and the Erivan K. Haub Family Professor of Cancer Research Honoring Richard F. Emslander, M.D. “While prior studies have focused on measuring TILs in people treated with chemotherapy, this is the largest study to comprehensively demonstrate that the presence of TILs influences the natural behavior of breast cancer in people who have surgery and/or radiation with no additional medical treatment.”

For this study, Mayo Clinic and Gustave Roussy researchers, in collaboration with the International Immuno-Oncology Biomarker Working Group, led 11 additional groups to collect data on 1,966 participants with early-stage TNBC who only underwent surgery with or without radiation therapy but did not receive chemotherapy. The participants had been followed for a median of 18 years. The results showed that higher levels of TILs in breast cancer tissue were associated with lower recurrence rates among participants with early-stage TNBC.

“Five years after surgery, 95% of participants with small tumors, stage 1 TNBC, and whose tumors had high TILs were alive, compared to 82% of patients whose tumors had low TILs. Importantly, the breast cancer recurrence rate was significantly lower among patients whose tumors had high TILs,” says co-senior author, Stefan Michiels, Ph.D., head of Oncostat team, Gustave Roussy, Inserm U1018, University Paris-Saclay. “With nearly 2,000 participants involved in the study, we have now assembled the largest international cohort across three continents of people with TNBC in which the primary treatment was surgery without chemotherapy.”

“The results of this study could lead to a recommendation to include TILs in the pathology reports of early-stage TNBC worldwide, as it has the potential to inform clinicians and patients when they discuss treatment options,” says Dr. Salgado.

Furthermore, this biomarker would only require a visual evaluation by a pathologist looking through a microscope, meaning there are no additional costs associated with identifying the presence of immune cells. This could be particularly beneficial to regions with limited resources, adds Dr. Leon-Ferre.

Most people with early-stage TNBC undergo chemotherapy either before or after surgery, including people with stage 1 breast cancer. Most people receive multiple chemotherapy drugs in combination, which can cause significant side effects. Currently, the main factors taken into consideration to determine the course of chemotherapy treatment for each person are the tumor size and the presence of lymph node metastases. However, the authors identified that the number of TILs further influences the risk of future recurrence.

The researchers plan to evaluate TILs as biomarkers in prospective clinical trials evaluating chemotherapy selection based on TIL levels. Ongoing efforts to conduct additional research with other potential biomarkers are underway.

For a complete list of authors, disclosures and funding, see the full paper here.  

###

About Mayo Clinic Comprehensive Cancer Center
Designated as a comprehensive cancer center by the National Cancer Institute, Mayo Clinic Comprehensive Cancer Center is defining new boundaries in possibility, focusing on patient-centered care, developing novel treatments, training future generations of cancer experts and bringing cancer research to communities. At Mayo Clinic Comprehensive Cancer Center, a culture of innovation and collaboration is driving research breakthroughs that are changing approaches to cancer prevention, screening and treatment, and improving the lives of cancer survivors.

About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the Mayo Clinic News Network for additional Mayo Clinic news.

About Gustave Roussy
Ranked as the leading French and European Cancer Centre and fourth in the world, Gustave Roussy is a centre with comprehensive expertise and is devoted entirely to patients suffering with cancer. The Institute is a founding member of the Paris Saclay Cancer Cluster. It is a source of diagnostic and therapeutic advances. It caters for almost 50,000 patients per year and its approach is one that integrates research, patient care and teaching. It is specialized in the treatment of rare cancers and complex tumors and it treats all cancers in patients of any age. Its care is personalized and combines the most advanced medical methods with an appreciation of the patient’s human requirements. In addition to the quality of treatment offered, the physical, psychological and social aspects of the patient’s life are respected. 4,100 professionals work on its two campuses: Villejuif and Chevilly-Larue. Gustave Roussy brings together the skills, which are essential for the highest quality research in oncology: 40% of patients treated are included in clinical studies. For further information: www.gustaveroussy.fr/en, Twitter, Facebook, LinkedIn, Instagram

Media contact:

Kelley Luckstein, Mayo Clinic Communications, newsbureau@mayo.edu





Source link

Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
Previous Article7 Financial Mistakes to Avoid in Your 20s
Next Article How to Stop Fighting and Start Communicatin…
admin
  • Website

Related Posts

Low carb biscotti with almonds and pistachios

November 13, 2026

Low carb lomo saltado with kohlrabi fries

November 11, 2026

Low carb chicken Pad Thai with zoodles

November 6, 2026

Keto olive oil cake with whipped cream

November 1, 2026

Leave A Reply Cancel Reply

Demo
Stay In Touch
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • YouTube
  • Vimeo
Don't Miss
Weight Loss

Keto avocado toast with crispy feta eggs

By adminNovember 14, 20260

Recipe notes and tips What are crispy feta eggs? Crispy feta eggs are a popular…

Low carb biscotti with almonds and pistachios

November 13, 2026

Perspective vs Prescription: Hard Days Make for Soft Landings

November 13, 2026

At 43, Robert Strauss Continues Training to Be the ‘Dad Bod Destroyer’

November 13, 2026

Subscribe to Updates

Get the latest creative news from SmartMag about art & design.

About Us
About Us

Welcome to our fitness blog! We are a team of passionate fitness enthusiasts committed to sharing valuable information and tips on health, fitness, nutrition, and wellness. Join us on our journey to a healthier lifestyle!

Our Picks

At 43, Robert Strauss Continues Training to Be the ‘Dad Bod Destroyer’

November 13, 2026

Sweet Potato Dessert for Menopause (No Added Sugar)

November 13, 2026

Keto chicken and waffles with poached eggs

November 13, 2026
Catagories
  • Diet & Nutrition
  • Weight Loss
  • Lifestyle
  • Mental Well-Being
  • Self Improvements
  • Workouts & Exercise
  • News
Facebook Twitter Instagram Pinterest WhatsApp
© 2026 Fitnessvivid.com.

Type above and press Enter to search. Press Esc to cancel.

Sign In or Register

Welcome Back!

Login to your account below.

Lost password?